Skip to search.
 TSX Up 0.47% TSX Ventures Up 1.46%

Titan Pharmaceuticals Inc. (TTNP)

-NasdaqCM
5.95 Down 0.34(5.41%) Apr 29, 4:00PM EDT
Prev Close:6.29
Open:6.27
Bid:5.90 x 1000
Ask:7.75 x 600
1y Target Est:7.75
Beta:1.5566
Earnings Date:May 11 - May 16 (Est.)
Day's Range:5.87 - 6.39
52wk Range:2.57 - 10.00
Volume:319,484
Avg Vol (3m):208,875
Market Cap:119.36M
P/E (ttm):N/A
EPS (ttm):-0.51
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
TTNPDown 5.41%119.36M
LLYDown 1.22%80.29B
PFEDown 0.61%202.54B
JNJDown 0.36%309.15B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):48.85
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :0.27
Quarterly EPS Est (Mar-16) :-0.12
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Titan Pharmaceuticals, Inc., a specialty pharmaceutical company, develops proprietary therapeutics for the treatment of serious medical disorders in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback